These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8939199)

  • 1. Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred).
    Piccardo P; Seiler C; Dlouhy SR; Young K; Farlow MR; Prelli F; Frangione B; Bugiani O; Tagliavini F; Ghetti B
    J Neuropathol Exp Neurol; 1996 Nov; 55(11):1157-63. PubMed ID: 8939199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.
    Piccardo P; Liepnieks JJ; William A; Dlouhy SR; Farlow MR; Young K; Nochlin D; Bird TD; Nixon RR; Ball MJ; DeCarli C; Bugiani O; Tagliavini F; Benson MD; Ghetti B
    Am J Pathol; 2001 Jun; 158(6):2201-7. PubMed ID: 11395398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Fiorini M; Ferrari S; Meade-White K; Barbieri I; Brocchi E; Ghetti B; Monaco S
    J Biol Chem; 2014 Feb; 289(8):4870-81. PubMed ID: 24398683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred.
    Giaccone G; Verga L; Bugiani O; Frangione B; Serban D; Prusiner SB; Farlow MR; Ghetti B; Tagliavini F
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9349-53. PubMed ID: 1357663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gerstmann-Sträussler-Scheinker Disease with F198S Mutation Induces Independent Tau and Prion Protein Pathologies in Bank Voles.
    Bruno R; Pirisinu L; Riccardi G; D'Agostino C; De Cecco E; Legname G; Cardone F; Gambetti P; Nonno R; Agrimi U; Di Bari MA
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity.
    Piccardo P; Dlouhy SR; Lievens PM; Young K; Bird TD; Nochlin D; Dickson DW; Vinters HV; Zimmerman TR; Mackenzie IR; Kish SJ; Ang LC; De Carli C; Pocchiari M; Brown P; Gibbs CJ; Gajdusek DC; Bugiani O; Ironside J; Tagliavini F; Ghetti B
    J Neuropathol Exp Neurol; 1998 Oct; 57(10):979-88. PubMed ID: 9786248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.
    Parchi P; Chen SG; Brown P; Zou W; Capellari S; Budka H; Hainfellner J; Reyes PF; Golden GT; Hauw JJ; Gajdusek DC; Gambetti P
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8322-7. PubMed ID: 9653185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
    Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.
    Tagliavini F; Prelli F; Ghiso J; Bugiani O; Serban D; Prusiner SB; Farlow MR; Ghetti B; Frangione B
    EMBO J; 1991 Mar; 10(3):513-9. PubMed ID: 1672107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of abnormal prion protein isoforms between Gerstmann-Sträussler-Scheinker syndrome and Creutzfeldt-Jakob disease.
    Furukawa H; Doh-ura K; Kikuchi H; Tateishi J; Iwaki T
    J Neurol Sci; 1998 Jun; 158(1):71-5. PubMed ID: 9667781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP.
    Yang W; Cook J; Rassbach B; Lemus A; DeArmond SJ; Mastrianni JA
    J Neurosci; 2009 Aug; 29(32):10072-80. PubMed ID: 19675240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele.
    Tagliavini F; Prelli F; Porro M; Rossi G; Giaccone G; Farlow MR; Dlouhy SR; Ghetti B; Bugiani O; Frangione B
    Cell; 1994 Nov; 79(4):695-703. PubMed ID: 7954833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles.
    Mercer RCC; Daude N; Dorosh L; Fu ZL; Mays CE; Gapeshina H; Wohlgemuth SL; Acevedo-Morantes CY; Yang J; Cashman NR; Coulthart MB; Pearson DM; Joseph JT; Wille H; Safar JG; Jansen GH; Stepanova M; Sykes BD; Westaway D
    PLoS Pathog; 2018 Jan; 14(1):e1006826. PubMed ID: 29338055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165.
    Piccardo P; Ghetti B; Dickson DW; Vinters HV; Giaccone G; Bugiani O; Tagliavini F; Young K; Dlouhy SR; Seiler C
    J Neuropathol Exp Neurol; 1995 Nov; 54(6):790-801. PubMed ID: 7595652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration.
    Alzualde A; Indakoetxea B; Ferrer I; Moreno F; Barandiaran M; Gorostidi A; Estanga A; Ruiz I; Calero M; van Leeuwen FW; Atares B; Juste R; Rodriguez-Martínez AB; López de Munain A
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):789-800. PubMed ID: 20613639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [
    Risacher SL; Farlow MR; Bateman DR; Epperson F; Tallman EF; Richardson R; Murrell JR; Unverzagt FW; Apostolova LG; Bonnin JM; Ghetti B; Saykin AJ
    Acta Neuropathol Commun; 2018 Oct; 6(1):114. PubMed ID: 30373672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards authentic transgenic mouse models of heritable PrP prion diseases.
    Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
    Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding.
    Zaidi SI; Richardson SL; Capellari S; Song L; Smith MA; Ghetti B; Sy MS; Gambetti P; Petersen RB
    J Alzheimers Dis; 2005 Apr; 7(2):159-71; discussion 173-80. PubMed ID: 15851854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryo-EM structures of prion protein filaments from Gerstmann-Sträussler-Scheinker disease.
    Hallinan GI; Ozcan KA; Hoq MR; Cracco L; Vago FS; Bharath SR; Li D; Jacobsen M; Doud EH; Mosley AL; Fernandez A; Garringer HJ; Jiang W; Ghetti B; Vidal R
    Acta Neuropathol; 2022 Sep; 144(3):509-520. PubMed ID: 35819518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.
    Tunnell E; Wollman R; Mallik S; Cortes CJ; Dearmond SJ; Mastrianni JA
    Neurology; 2008 Oct; 71(18):1431-8. PubMed ID: 18955686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.